Article
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN - 1 Feb 2020
Wierda William G, Byrd John C, Abramson Jeremy S, Bilgrami Syed F, Bociek Greg, Brander Danielle, Brown Jennifer, Chanan-Khan Asher A, Chavez Julio C, Coutre Steve E, Davis Randall S, Fletcher Christopher D, Hill Brian, Kahl Brad S, Kamdar Manali, Kaplan Lawrence D, Khan Nadia, Kipps Thomas J, Lim Megan S, Ma Shuo, Malek Sami, Mato Anthony, Mosse Claudio, Shadman Mazyar, Siddiqi Tanya, Stephens Deborah, Sundaram Suchitra, Wagner Nina, Dwyer Mary, Sundar Hema
Abstract excerpt
Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are characterized by a progressive accumulation of leukemic cells in the peripheral blood, bone marrow, and lymphoid tissues. Treatment of CLL/SLL has evolved significantly in recent years because of the improved understanding of the disease biology and the development of novel targeted therapies. In patients with indications for initiating...
Topics
Join the communities discussing this publication.